Status:
NOT_YET_RECRUITING
Use of a New Smartphone Application to Determine Changes in Eyeblink Conditioning From Home Training in Individuals With Spinocerebellar Ataxia
Lead Sponsor:
Columbia University
Conditions:
Spinocerebellar Ataxias
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Spinocerebellar ataxias are a group of disorders that cause severe disability and can be fatal. There are currently no known disease-modifying treatments available for use, and there is a critical nee...
Detailed Description
Spinocerebellar ataxias are a group of disorders that cause severe disability due to progressive incoordination. With no FDA approved medications, there is a critical need to find effective treatments...
Eligibility Criteria
Inclusion
- Diagnosed with spinocerebellar ataxia
- Cerebellar atrophy on MRI
- Prevalence of ataxia on clinical exam (SARA \>2)
- Ability to safely ride a stationary exercise bike (SARA sitting sub-score \<3)
Exclusion
- Parkinson's Disease
- Traumatic Brain Injury
- Stroke
- Alzheimer's Disease
- Heart disease
- Dementia
- Medical instability
- Inability to walk without assistance (SARA gait sub-score \>6).
Key Trial Info
Start Date :
January 1 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06177626
Start Date
January 1 2026
End Date
October 1 2027
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Columbia University/New York Presbyterian
New York, New York, United States, 10035